Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study (Q38777059)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 May 2017

Language	Label	Description	Also known as
English	Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study	scientific article published on 18 May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

author name string

G Spera

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

R Fresco

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

H Fung

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

J R B Dyck

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

E Pituskin

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

I Paterson

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

J R Mackey

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

18 May 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1836-1841

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

The sympathetic nervous system induces a metastatic switch in primary breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Reply to H.J. Lee et al.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Chronic social isolation is associated with metabolic gene expression changes specific to mammary adipose tissue

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX264

21 January 2018

Identifiers

10.1093/ANNONC/MDX264

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38777059&oldid=1786547417"